135095-52-2
Chemical Structure
Camelliaside A
- CAS No.: 135095-52-2
- Formula:C33H40O20
- Molecular Weight:756.66
IUPAC Name: 3-(((2S,3R,4S,5S,6R)-4,5-dihydroxy-3-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one
InChIKey: VNLOLXSJMINBIS-XWAGUSETSA-N
SMILES: O=C1C(O[C@H]2[C@@H]([C@H]([C@H](O)[C@@H](CO[C@H]3[C@@H]([C@@H]([C@@H](O)[C@H](C)O3)O)O)O2)O)O[C@]4([H])O[C@@H]([C@H](O)[C@H](O)[C@H]4O)CO)=C(C5=CC=C(O)C=C5)OC6=CC(O)=CC(O)=C61
Biological Activity: Camelliaside A is a phytochemical and also a HER2 ligand. Camelliaside A shows no inhibitory effect on mycelial growth of Rhizoctonia solani, indicating no antifungal activity against this pathogen. Camelliaside A is applicable to breast cancer-related research[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Camelliaside A | 99.65% | Camelliaside A is a phytochemical and also a HER2 ligand. Camelliaside A shows no inhibitory effect on mycelial growth of Rhizoctonia solani, indicating no antifungal activity against this pathogen. Camelliaside A is applicable to breast cancer-related research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Camelliaside A (Standard) | ≥98% | Camelliaside A (Standard) is the analytical standard of Camelliaside A. This product is intended for research and analytical applications. Camelliaside A is a flavonoid from the methanol extract of tea (Camellia oleifera) seed pomace. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Kuo PC, et al. Bioactive saponin from tea seed pomace with inhibitory effects against Rhizoctonia solani. J Agric Food Chem. 2010;58(15):8618-8622. [Content Brief]
-
[2]. Ebenyi, Lilian N., et al. Identification of Some Bioactive Compounds from Camelia Sinensis as Possible Inhibitors of HER2: A Structure-Based Drug Design for Breast Cancer Treatment. Available at SSRN 4078794 (2022).
